無料プレビュー

Exact Sciences Corporation (EXAS) · NASDAQ Capital Market

プロフィール

Exact Sciences Corporation is a leading provider of cancer screening and diagnostic tests that deliver earlier detection and treatment guidance through molecular and genomic analysis. The company offers Cologuard and Cologuard Plus stool-based DNA screening tests for colorectal cancer, Cancerguard multi-cancer early detection blood test, Oncotype DX precision oncology tests for breast and colon cancer treatment planning, Oncodetect molecular residual disease monitoring test, and other genomic diagnostic products. The company operates through screening and precision oncology segments, commercia

主要指標

株価: $104.91 (0.00%)
時価総額: 200億ドル
PER（今期予想）: 582.8
PBR: 8.3
配当利回り: —
52週レンジ: $38.81 – $104.98
業種: Healthcare / Medical - Diagnostics & Research
上場: NASDAQ Capital Market
構成銘柄: —

比較会社: TMO Thermo Fisher Scientific Inc.、DHR Danaher Corporation、NTRA Natera, Inc.、A Agilent Technologies, Inc.、IQV IQVIA Holdings Inc.、WAT Waters Corporation、IDXX IDEXX Laboratories, Inc.、ILMN Illumina, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

更新: 2026-10-09